These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31621617)

  • 1. Transcranial sonography in atypical parkinsonism: How reliable is it in real clinical practice? A multicentre comprehensive study.
    Alonso-Canovas A; Tembl Ferrairó JI; Martínez-Torres I; Lopez-Sendon Moreno JL; Parees-Moreno I; Monreal-Laguillo E; Pérez-Torre P; Toledano Delgado R; García Ribas G; Sastre Bataller I; Masjuan J; Martinez-Castrillo JC; Walter U
    Parkinsonism Relat Disord; 2019 Nov; 68():40-45. PubMed ID: 31621617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease.
    Walter U; Dressler D; Probst T; Wolters A; Abu-Mugheisib M; Wittstock M; Benecke R
    Arch Neurol; 2007 Nov; 64(11):1635-40. PubMed ID: 17998447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcranial sonography for the discrimination of idiopathic Parkinson's disease from the atypical parkinsonian syndromes.
    Bouwmans AE; Vlaar AM; Srulijes K; Mess WH; Weber WE
    Int Rev Neurobiol; 2010; 90():121-46. PubMed ID: 20692498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal ganglia echogenicity in tauopathies.
    Sadowski K; Serafin-Król M; Szlachta K; Friedman A
    J Neural Transm (Vienna); 2015 Jun; 122(6):863-5. PubMed ID: 25204278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.
    Fujita H; Suzuki K; Numao A; Watanabe Y; Uchiyama T; Miyamoto T; Miyamoto M; Hirata K
    PLoS One; 2016; 11(11):e0165869. PubMed ID: 27812167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcranial sonography of the substantia nigra in Japanese patients with Parkinson's disease or atypical parkinsonism: clinical potential and limitations.
    Okawa M; Miwa H; Kajimoto Y; Hama K; Morita S; Nakanishi I; Kondo T
    Intern Med; 2007; 46(18):1527-31. PubMed ID: 17878638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcranial sonography and [18F]fluorodeoxyglucose positron emission tomography for the differential diagnosis of parkinsonism: a head-to-head comparison.
    Hellwig S; Reinhard M; Amtage F; Guschlbauer B; Buchert R; Tüscher O; Weiller C; Niesen WD; Meyer PT
    Eur J Neurol; 2014 Jun; 21(6):860-6. PubMed ID: 24602186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentiform Nucleus Hyperechogenicity in Parkinsonian Syndromes: A Systematic Review and Meta-Analysis with Consideration of Molecular Pathology.
    Richter D; Katsanos AH; Schroeder C; Tsivgoulis G; Paraskevas GP; Müller T; Alexandrov AV; Gold R; Tönges L; Krogias C
    Cells; 2019 Dec; 9(1):. PubMed ID: 31861253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiating progressive supranuclear palsy from other movement disorders using transcranial sonography: a systematic review and meta-analysis.
    Wen Y; Zhou H; Xia M; Liu Q; Quan H; Fang L
    Neurol Sci; 2024 Feb; 45(2):455-465. PubMed ID: 37819487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy.
    Walter U; Dressler D; Wolters A; Probst T; Grossmann A; Benecke R
    Neurology; 2004 Aug; 63(3):504-9. PubMed ID: 15304582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesencephalic area measured by transcranial sonography in the differential diagnosis of parkinsonism.
    Sastre-Bataller I; Vázquez JF; Martínez-Torres I; Sahuquillo P; Rubio-Agustí I; Burguera JA; Ferrer JM; Valero C; Tembl JI
    Parkinsonism Relat Disord; 2013 Aug; 19(8):732-6. PubMed ID: 23684370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcranial Brain Sonography in Parkinson's Disease and Other Parkinsonian Disorders: a Hospital Study from Tuzla, Bosnia and Herzegovina.
    Smajlovic D; Ibrahimagic OC
    Med Arch; 2017 Aug; 71(4):261-264. PubMed ID: 28974846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of transcranial sonography-magnetic resonance fusion imaging in Wilson's and early-onset Parkinson's diseases.
    Mašková J; Školoudík D; Burgetová A; Fiala O; Brůha R; Záhoráková D; Serranová T; Slovák M; Ulmanová O; Růžička E; Dušek P
    Parkinsonism Relat Disord; 2016 Jul; 28():87-93. PubMed ID: 27147115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease.
    Walter U; Wittstock M; Benecke R; Dressler D
    J Neural Transm (Vienna); 2002 Feb; 109(2):191-6. PubMed ID: 12075859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcranial Sonographic Alterations of Substantia Nigra and Third Ventricle in Parkinson's Disease with or without Dementia.
    Dong ZF; Wang CS; Zhang YC; Zhang Y; Sheng YJ; Hu H; Luo WF; Liu CF
    Chin Med J (Engl); 2017 Oct; 130(19):2291-2295. PubMed ID: 28937033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminating among degenerative parkinsonisms using advanced (123)I-ioflupane SPECT analyses.
    Badoud S; Van De Ville D; Nicastro N; Garibotto V; Burkhard PR; Haller S
    Neuroimage Clin; 2016; 12():234-40. PubMed ID: 27489771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.
    Walter U; Hoeppner J; Prudente-Morrissey L; Horowski S; Herpertz SC; Benecke R
    Brain; 2007 Jul; 130(Pt 7):1799-807. PubMed ID: 17329323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes.
    Walter U; Niehaus L; Probst T; Benecke R; Meyer BU; Dressler D
    Neurology; 2003 Jan; 60(1):74-7. PubMed ID: 12525721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of transcranial sonography in parkinson spectrum disorders in comparison to degenerative cognitive syndromes.
    Laučkaitė K; Rastenytė D; Šurkienė D; Vaitkus A; Sakalauskas A; Lukoševičius A; Gleiznienė R
    BMC Neurol; 2012 Mar; 12():12. PubMed ID: 22400906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine transporter SPECT imaging in Parkinson's disease and atypical Parkinsonism: a study of 137 patients.
    Constantinides VC; Souvatzoglou M; Paraskevas GP; Chalioti M; Stefanis L; Kapaki E
    Neurol Sci; 2023 May; 44(5):1613-1623. PubMed ID: 36658411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.